Layla D. Berry

Array ( [id] => 17052161 [patent_doc_number] => 20210261595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => PRODUCTION METHOD FOR GUANOSINE DERIVATIVE HAVING FLUORINE ATOM-CONTAINING FUNCTIONAL GROUP AT POSITION 8 AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/275083 [patent_app_country] => US [patent_app_date] => 2019-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4465 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16605935 [patent_doc_number] => 10906927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-02 [patent_title] => Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility [patent_app_type] => utility [patent_app_number] => 16/553200 [patent_app_country] => US [patent_app_date] => 2019-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 16951 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15553361 [patent_doc_number] => 20200061092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH MUSCLE WEAKNESS [patent_app_type] => utility [patent_app_number] => 16/549986 [patent_app_country] => US [patent_app_date] => 2019-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16116 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16549986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17625727 [patent_doc_number] => 20220160742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => USE OF LUTEOLIN-7-O-GLUCOSIDE OR LUTEOLIN-7-O-GLUCURONIDE IN PREPARATION OF MEDICINE FOR EYE INJURIES [patent_app_type] => utility [patent_app_number] => 17/598913 [patent_app_country] => US [patent_app_date] => 2019-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17022286 [patent_doc_number] => 20210246157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => CAMPTOTHECIN DERIVATIVES AND PREPARATION METHODS AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/270063 [patent_app_country] => US [patent_app_date] => 2019-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10699 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16991787 [patent_doc_number] => 20210230207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => NOVEL ALL-TRANS POLYENE AMPHOTERIC MACROLIDE [patent_app_type] => utility [patent_app_number] => 17/267790 [patent_app_country] => US [patent_app_date] => 2019-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4591 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16915800 [patent_doc_number] => 20210188892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => NOVEL EPOXIDE POLYENE AMPHOTERIC MACROLIDE AND PROCESS FOR PURIFYING NATAMYCIN [patent_app_type] => utility [patent_app_number] => 17/268252 [patent_app_country] => US [patent_app_date] => 2019-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4591 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17268252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17156103 [patent_doc_number] => 20210317154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => METHOD FOR PRODUCING SUGAR FATTY ACID ESTER BY TRANSESTERIFICATION REACTION [patent_app_type] => utility [patent_app_number] => 17/265666 [patent_app_country] => US [patent_app_date] => 2019-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4107 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15405349 [patent_doc_number] => 20200022996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/531849 [patent_app_country] => US [patent_app_date] => 2019-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16769 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18801317 [patent_doc_number] => 11834469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-05 [patent_title] => AMP-activated protein kinase activating compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 17/259892 [patent_app_country] => US [patent_app_date] => 2019-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9313 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15430825 [patent_doc_number] => 20200029595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => SACCHARIDES AND SACCHARIDE COMPOSTIONS AND MIXTURES [patent_app_type] => utility [patent_app_number] => 16/529986 [patent_app_country] => US [patent_app_date] => 2019-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11422 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16529986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19975373 [patent_doc_number] => 12342822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-01 [patent_title] => Pesticides and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/265787 [patent_app_country] => US [patent_app_date] => 2019-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8066 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15407951 [patent_doc_number] => 20200024297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF [patent_app_type] => utility [patent_app_number] => 16/528414 [patent_app_country] => US [patent_app_date] => 2019-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77041 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16528414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15454567 [patent_doc_number] => 20200040108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES [patent_app_type] => utility [patent_app_number] => 16/525629 [patent_app_country] => US [patent_app_date] => 2019-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17141670 [patent_doc_number] => 20210309682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => PROCESS FOR PREPARING MANNOSE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/263012 [patent_app_country] => US [patent_app_date] => 2019-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17005471 [patent_doc_number] => 20210236632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 17/263515 [patent_app_country] => US [patent_app_date] => 2019-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -141 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17005471 [patent_doc_number] => 20210236632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 17/263515 [patent_app_country] => US [patent_app_date] => 2019-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -141 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17005471 [patent_doc_number] => 20210236632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 17/263515 [patent_app_country] => US [patent_app_date] => 2019-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -141 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17814304 [patent_doc_number] => 11419891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions [patent_app_type] => utility [patent_app_number] => 17/260272 [patent_app_country] => US [patent_app_date] => 2019-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 34680 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17110063 [patent_doc_number] => 20210290660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => HIGHLY PURIFIED AND/OR MODIFIED FUCAN COMPOSITIONS FOR THE TREATMENT OF FIBROUS ADHESIONS [patent_app_type] => utility [patent_app_number] => 17/260288 [patent_app_country] => US [patent_app_date] => 2019-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26909 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260288 [rel_patent_id] =>[rel_patent_doc_number] =>)